Membership & Professional Standards Committee

Slides:



Advertisements
Similar presentations
Membership & Professional Standards Committee (MPSC)
Advertisements

Definition of a Transplant Hospital Membership and Professional Standards Committee Fall 2014.
Membership and Personnel Requirements for VCA Programs (Resolution 27) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid,
Histocompatibility Bylaws Rewrite: Phase 2 Histocompatibility Committee Fall 2014.
Proposal to Change the OPTN/UNOS Bylaws to Better Define Notification Requirements for Periods of Functional Inactivity Membership and Professional Standards.
Proposal to Clarify Data Submission Reporting and Documentation Requirements (Resolution 22) Membership & Professional Standards Committee (MPSC) Jonathan.
Proposed Membership and Personnel Requirements for Intestine Transplant Programs Liver and Intestinal Organ Transplantation Committee Spring 2015.
Proposal to Require Reporting of Every Islet Infusion to the OPTN Contractor within 24 Hours of the Infusion Pancreas Transplantation Committee Fall 2012.
Policy Oversight Committee Update Board of Directors Meeting June 25-26, 2012 Stuart C. Sweet, MD, PhD.
1 Region 10 Meeting Tim Taber, MD Regional Councillor.
1 Addressing the Term “Foreign Equivalent” in OPTN/UNOS Bylaws Membership and Professional Standards Committee Fall 2015.
OPTN Bylaws Substantive Rewrite of the Bylaws Addressing Review, Actions, and Due Process Sponsored by the Membership and Professional Standards Committee.
Membership & Professional Standards Committee (MPSC) Spring 2014.
Liver and Intestinal Organ Transplantation Committee Update David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Improving the OPTN Policy Development Process Executive Committee Fall 2014.
1 Membership and Professional Standards Committee Fall 2015.
Membership & Professional Standards Committee (MPSC)
Updating Primary Kidney Transplant Physician Requirements
Pediatric Transplantation Committee
Rewrite of Article II: Board of Directors
Pediatric Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Revisions to Pediatric Emergency Membership Exception
OPTN Bylaws Rewrite Appendix L: Reviews, Actions, and Due Process
Membership & Professional Standards Committee (MPSC)
Changes to OPTN Bylaws Appendix L
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Pediatric Transplantation Committee
Guidance for ABO Subtyping Organ Donors for Blood Groups A and AB
Transplant Administrators Committee (TAC)
Membership and Professional Standards Committee
Histocompatibility Laboratory Bylaws and Policies Guidance Document
Pediatric Transplantation Committee
Pediatric Transplantation Committee
Mark S. Orloff, MD Regional Councillor
OPTN/UNOS Thoracic Organ Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Membership & Professional Standards Committee
Updating the OPTN Definition of a Transplant Hospital
Region 7 Nominating Guidelines
Changes to Islet Bylaws
Action Items from the Kidney Transplantation Committee
Membership and Professional Standards Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Changes to Hospital-Based OPO (HOPO) Voting Privileges
Thoracic Organ Transplantation Committee
Operations and Safety Committee
Membership & Professional Standards Committee (MPSC)
Pediatric Transplantation Committee
The OPTN Bylaws Rewrite Project What It Means For You
Vascularized Composite Allograft (VCA) Transplantation Committee
Membership & Professional Standards Committee Spring 2014
Liver and Intestinal Organ Transplantation Committee Spring 2014
Pediatric Transplantation Committee Regional Meeting Update Fall 2012
Marlon F. Levy, MD Regional Councillor
Vascularized Composite Allograft (VCA) Transplantation Committee
Policy Rewrite Parking Lot Quick Fixes
Addressing Approved Transplant Fellowship Training Programs Bylaws
Living Donor Committee
Membership & Professional Standards Committee Fall 2014
Membership and Professional Standards Committee
Elizabeth A. Pomfret, MD, PhD Regional Councillor
Region 8 Meeting Harvey Solomon, MD
Pediatric Transplantation Committee
Fall 2012 Public Comment Cycle
Living Donor Committee
Membership & Professional Standards Committee (MPSC)
VCA Committee Update Spring 2015.
OPTN/UNOS Histocompatibility Committee
Presentation transcript:

Membership & Professional Standards Committee Fall 2012

Bylaw Implementation Dates September 1: OPTN Bylaws Rewrite – Appendices A-K and M (Phase 1 – Plain language) OPTN Bylaws, Appendix L, addressing reviews, actions, and due process (substantive and plain language changes) During its June meeting the Board of Directors approved two MPSC proposals that had completed the public comment process. These changes will be effective on September 1: The OPTN Bylaws Plain Language Rewrite was undertaken to rewrite the Bylaws in plain language and to reorganize the Bylaws for better clarity and usability. This rewrite did not make any substantive changes to the content of the current Bylaws, but only changes the current language to make it easier to understand with more consistent terminology, better organization, and new usability features, including a table of contents. At that same meeting, the Board approved both a substantive and plain language rewrite to the bylaws pertaining to Reviews, Actions, and Due Process.  The new Appendix L represents a substantive rewrite of the procedures for reviewing potential violations of and non-compliance with OPTN obligations. <Speaker Notes> The OPTN Bylaws Substantive Rewrite of the bylaws addressing reviews, actions, and due process accomplishes the following objectives:   Outlines the three possible review pathways for potential violations of OPTN obligations and requirements. Clarifies the role of Secretary of the U.S. Department of Health and Human Services (HHS) in reviewing and acting on potential violations, particularly those that may pose a threat to patient health and public safety. Clarifies when the Secretary may request that the OPTN Contractor perform special reviews of a Member for non-compliance. Adds a new monitoring tool to aid Members who may need time and assistance from the OPTN to come into compliance. Clarifies notice requirements after an adverse action is taken by the OPTN. Provides information to Members about their rights in plain language with logical organization.

Ongoing Committee Initiatives Modified Outcomes Flagging Methodology Goal: Better identify transplant programs that could truly benefit from intervention Outcomes data using existing and new methodology studied in parallel for several CSR cycles and reviewed by MPSC Modified flagging methodology will be recommended by the MPSC as the sole flagging method Proposal will be distributed for public comment during Spring 2013 The MPSC has proposed modifications to the post-transplant outcomes flagging methodology to better identify transplant programs that could truly benefit from intervention. Outcomes data using existing and new methodology were studied in parallel for several Center Specific Report (CSR) cycles and reviewed by the Performance Analysis and Improvement Subcommittee (PAIS) and MPSC. In March 2012, the MPSC recommending adopting the modified flagging methodology as the sole flagging method. Bylaw language was approved in July 2012, and the proposal will be distributed for public comment in the Spring 2013.

New Committee Initiatives Bylaws Rewrite – Phase 2 Procedures for reviewing applications Process for submitting letters of reference Primary surgeon/physician currency requirements Clarification of reporting requirements for changes in key personnel at OPO’s and Histo Labs Intestinal Transplant Program Requirements (led by Liver/Intestine Committee) The Committee will also be reviewing issues that were identified during Phase I of the Bylaws rewrite that were too substantive in nature to be amended then. Some of these projects were identified by the staff and others were brought up by the transplant community during the public comment process for Phase I. For example, the bylaws listed on this slide need to be updated to reflect current practices. The Committee and staff will begin working on these rewrites this fall. <Note for speaker. Primary personnel at OPO’s = executive director and medical director. Primary personnel at labs = lab director/technical supervisor>

Questions? Ken Andreoni MD, Committee Chair Kenneth.Andreoni@surgery.ufl.edu Alan Reed, MD, Vice Chair alan-reed@uiowa.edu Sally Aungier, MPSC Liaison Sally.aungier@unos.org